Delavirdine mesylate | U 90152 mesylate;BHAP-U 90152 mesylate;U 90152E;U90152T;U 90152T U-90152T;U-90152S;Rescriptor;Delavirdine (mesylate) | HIV | NNRTI

首页 / 抑制剂/激动剂 / 抗感染 / / Delavirdine mesylate

地拉韦啶甲磺酸盐 /Delavirdine mesylate 99+%

货号：A380147 同义名： U 90152 mesylate;BHAP-U 90152 mesylate 产品仅供科研

Delavirdine mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Delavirdine mesylate 化学结构
CAS号：147221-93-0

Delavirdine mesylate 3D分子结构
CAS号：147221-93-0

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费分装

免费溶解
下载资料

Delavirdine mesylate 纯度/质量文件

货号：A380147 标准纯度：99+% 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Mar. Drugs, 2024, 22(5): 194. Ambeed. [ A104599 ]; • Pharmaceuticals, 2024, 17(5): 570. Ambeed. [ A224421 ]; 更多 >

Delavirdine mesylate 生物活性

描述	Delavirdine mesylate is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine mesylate 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT00197145	Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 <<	Phase 3	Terminated	-	-
NCT00197145	-		Terminated	-	-
NCT03631732	HIV-1 Infection	Phase 3	Recruiting	August 2020	-

Delavirdine mesylate 参考文献

[1]Voorman RL, Payne NA, et al. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6. Drug Metab Dispos. 2001 Jan;29(1):41-7.

[2]Dueweke TJ, Poppe SM, et al. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother. 1993 May;37(5):1127-31.

Delavirdine mesylate 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

1.81mL

0.36mL

0.18mL

9.05mL

1.81mL

0.90mL

18.09mL

3.62mL

1.81mL

Delavirdine mesylate 技术信息

CAS号	147221-93-0
分子式	C₂₃H₃₂N₆O₆S₂
分子量	552.667

别名	U 90152 mesylate;BHAP-U 90152 mesylate;U 90152E;U90152T;U 90152T U-90152T;U-90152S;Rescriptor;Delavirdine (mesylate)
运输	蓝冰

存储条件

粉末 Inert atmosphere,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 40 mg/mL(72.38 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00197145	Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 <<	Phase 3	Terminated	-	-
NCT00197145	-		Terminated	-	-
NCT03631732	HIV-1 Infection	Phase 3	Recruiting	August 2020	-
NCT01814722	-		Terminated(The trial was termi... 展开 >>nated early due to slow recruitment.) 收起 <<	-	-
NCT01814722	-		Terminated(The trial was termi... 展开 >>nated early due to slow recruitment.) 收起 <<	-	-
NCT00002378	HIV Infections	Phase 3	Completed	-	-
NCT00445146	-		Completed	-	-
NCT00000891	HIV Infections	Phase 2	Completed	-	United States, Colorado ... 展开 >> Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Illinois Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States, 60612 United States, Ohio Case Western Reserve Univ Cleveland, Ohio, United States, 44106 收起 <<
NCT00006519	HIV Infection	Phase 1	Completed	-	United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 <<
NCT00445146	HIV Infections	Phase 2	Completed	-	-
NCT01137981	-		Recruiting	December 31, 2024	United States, North Carolina ... 展开 >> GSK Investigational Site Recruiting Wilmington, North Carolina, United States, 28405 Contact: US Clincal Trials Call Center 877-379-3718 Contact: EU Clinical Trials Call Center +44 (0) 20 8990 4466 收起 <<
NCT00005673	Healthy HIV I... 展开 >>nfection 收起 <<	Phase 1	Completed	-	United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 <<
NCT00624195	HIV Infections	Phase 2 Phase 3	Completed	-	United States, California ... 展开 >> HIV Neurobehavioral Research Center, University of California San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94110 United States, Maryland Johns Hopkins University- School of Medicine Baltimore, Maryland, United States, 21287 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York Mount Sinai Medical Center New York, New York, United States, 10024 收起 <<
NCT00624195	-		Completed	-	-
NCT00000892	HIV Infections	Not Applicable	Completed	-	-
NCT02016924	Acquired Immune Deficiency Syn... 展开 >>drome (AIDS) HIV Infections 收起 <<	Phase 2 Phase 3	Recruiting	December 2024	United States, California ... 展开 >> Pediatric Infectious Diseases Associate Recruiting Long Beach, California, United States, 90806 Principal Investigator: Jagmohan Batra, MD Children's Hospital Los Angeles Withdrawn Los Angeles, California, United States, 90027 United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Elizabeth McFarland, MD United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20852 Principal Investigator: Natella Rakhmanina United States, Florida University of South Florida Clinic at Children's Medical Services Recruiting Tampa, Florida, United States, 33620 Principal Investigator: Carina Rodriguez, MD United States, Georgia Emory-Children's Center- Ponce Family and Youth Clinic Completed Atlanta, Georgia, United States, 30308 United States, Massachusetts Boston Medical Center Withdrawn Boston, Massachusetts, United States, 02118 United States, New York Bellevue Hospital Recruiting New York, New York, United States, 10016 Principal Investigator: William Borkowsky, MD SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Principal Investigator: Leonard Weiner, MD United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Principal Investigator: Aditya Gaur, MD United States, Texas University of Texas Health Science Center of Houston Recruiting Houston, Texas, United States, 77030 Principal Investigator: Gloria Heresi, MD Argentina Hospital General de Agudos Dr. Cosme Argerich Recruiting Buenos Aires, Argentina, 1151 Principal Investigator: Diego Cecchini Helios Salud S.A. Recruiting Buenos Aires, Argentina, C1131ACG Principal Investigator: Maria R Bologna Hospital Ramos Mejía Recruiting Buenos Aires, Argentina, C1221ADC DF Principal Investigator: Irene Foradori Fundacion Huesped Recruiting Buenos Aires, Argentina Principal Investigator: Pedro Cahn Thailand Siriraj Hospital Mahidol University Recruiting Bangkok, Krung Thep Maha Nakhon, Thailand Principal Investigator: Kulkanya Chokephaibulkit The HIV NAT Research Collaboration Recruiting Bangkok, Krung Thep Maha Nakhon, Thailand Principal Investigator: Sivaporn Getechompol Srinagarind Hospital Khon Kaen University Recruiting Khon Kaen, Thailand Principal Investigator: Pope Kosalaraksa 收起 <<
NCT00002400	HIV Infections	Not Applicable	Completed	-	United States, New Jersey ... 展开 >> Pharmacia & Upjohn Peapack, New Jersey, United States, 07977 收起 <<
NCT00006326	HIV Infections	Not Applicable	Terminated	-	United States, California ... 展开 >> Susan Conner San Diego, California, United States, 92121 收起 <<
NCT00001094	HIV Infections	Phase 2	Withdrawn	-	United States, California ... 展开 >> Willow Clinic Menlo Park, California, United States, 94025 Stanford Univ Med Ctr Stanford, California, United States, 943055107 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 331361013 United States, Georgia Emory Univ Atlanta, Georgia, United States, 30308 United States, Hawaii Queens Med Ctr Honolulu, Hawaii, United States, 96816 Univ of Hawaii Honolulu, Hawaii, United States, 96816 United States, Illinois Louis A Weiss Memorial Hosp Chicago, Illinois, United States, 60640 United States, Louisiana Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, New York SUNY / Erie County Med Ctr at Buffalo Buffalo, New York, United States, 14215 Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 United States, North Carolina Carolinas Med Ctr Charlotte, North Carolina, United States, 28203 Moses H Cone Memorial Hosp Greensboro, North Carolina, United States, 27401 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 452670405 Ohio State Univ Hosp Clinic Columbus, Ohio, United States, 432101228 United States, Texas Univ of Texas Galveston Galveston, Texas, United States, 775550435 Puerto Rico Univ of Puerto Rico San Juan, Puerto Rico, 009365067 收起 <<
NCT00002178	HIV Infections	Phase 3	Completed	-	United States, California ... 展开 >> Dr Charles Farthing Los Angeles, California, United States, 90048 United States, Massachusetts Community Research Initiative Brookline, Massachusetts, United States, 02445 收起 <<
NCT00000882	HIV Infections	Phase 2	Completed	-	-
NCT00002236	HIV Infections	Not Applicable	Completed	-	United States, California ... 展开 >> AIDS Healthcare Foundation Los Angeles, California, United States, 90027 UCSF AIDS Research Institute San Francisco, California, United States, 94105 United States, New York Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10019 United States, Pennsylvania Anderson Clinical Research Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Univ of Tennessee / Div of Infect Dis / Dept of Med Memphis, Tennessee, United States, 38165 United States, Virginia Infectious Disease Physicians Inc Annandale, Virginia, United States, 22203 收起 <<
NCT00002401	HIV Infections	Not Applicable	Completed	-	United States, New Jersey ... 展开 >> Pharmacia & Upjohn Peapack, New Jersey, United States, 07977 收起 <<
NCT02249130	HIV Infections	Phase 2	Completed	-	-
NCT00002312	HIV Infections	Not Applicable	Completed	-	United States, Michigan ... 展开 >> Bronson Methodist Hosp / Upjohn Research Clinic Kalamazoo, Michigan, United States, 490074949 收起 <<
NCT00002124	HIV Infections	Phase 3	Completed	-	-
NCT00002211	HIV Infections	Not Applicable	Completed	-	United States, New Jersey ... 展开 >> Pharmacia & Upjohn Peapack, New Jersey, United States, 07977 收起 <<
NCT00002123	HIV Infections	Phase 3	Completed	-	-
NCT00000810	HIV Infections	Phase 1	Completed	-	United States, California ... 展开 >> Stanford CRS Stanford, California, United States, 943055107 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, District of Columbia Howard University Hosp., Div. of Infectious Diseases, ACTU Washington, District of Columbia, United States, 20059 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 331361013 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States United States, Ohio The Ohio State Univ. AIDS CRS Columbus, Ohio, United States 收起 <<
NCT00000803	HIV Infections	Phase 2	Completed	-	-
NCT00002210	HIV Infections	Phase 2	Completed	-	United States, New Jersey ... 展开 >> Pharmacia & Upjohn Peapack, New Jersey, United States, 07977 收起 <<
NCT00823966	-		Completed	-	-
NCT00002420	HIV Infections	Phase 2	Terminated	-	United States, California ... 展开 >> Pacific Oaks Med Group Beverly Hills, California, United States, 90211 收起 <<
NCT00823966	-		Completed	-	-

地拉韦啶甲磺酸盐 /Delavirdine mesylate 99+%

Delavirdine mesylate 纯度/质量文件

全球学术期刊中引用的产品

Delavirdine mesylate 生物活性

Delavirdine mesylate 临床研究

Delavirdine mesylate 参考文献

Delavirdine mesylate 实验方案

Delavirdine mesylate 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

地拉韦啶甲磺酸盐 /Delavirdine mesylate 99+%

Delavirdine mesylate 纯度/质量文件

全球学术期刊中引用的产品

Delavirdine mesylate 生物活性

Delavirdine mesylate 临床研究

Delavirdine mesylate 参考文献

Delavirdine mesylate 实验方案

Delavirdine mesylate 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z